Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

Rutgers Appoints Reynold Panettieri to Develop Clinical and Translational Science Institute

1/22/2016

0 Comments

 
​New Brunswick, NJ ― Reynold Panettieri, M.D., a pulmonologist from the University of Pennsylvania School of Medicine, has joined Rutgers Biomedical and Health Sciences (RBHS) to develop the university’s first clinical and translational science institute and serve as its director.  He will also be the vice chancellor for clinical and translational research.
 
Dr. Panettieri, leaving his current role as the Robert L. Mayock and David A. Cooper Professor of Pulmonology Medicine at UPenn, assumed his position last month.
 
Brian Strom, chancellor of RBHS, said Rutgers’ commitment to clinical and translational science is vital to its continued evolution into one of the country’s leading academic health centers.  
​“Translational science is a new and evolving paradigm that makes it easier to translate bench research into new drugs, treatment options and devices that will improve patient and community health,” Strom said. “That clinical and translational science has become a priority for the National Institutes of Health reflects its importance.”
 
Translational science describes the collaborative process involving a combination of scientists — which may include researchers, clinicians, biologists and members of the pharmaceutical industry — to address an unmet medical need, such as the development of cancer drug therapy with reduced toxicity or a best-practices community approach to treating asthma.
 
Dr. Panettieri’s experience leading major centers at UPenn and his research and expertise in clinical and translational research for chronic obstructive pulmonary disease (COPD) and asthma made him an outstanding choice to head the institute, Strom said.
 
“With his stature and reputation, we greatly enhance our ability to undertake major multidisciplinary collaborations and compete strongly for NIH clinical research funding,” Strom said.
 
Dr. Panettieri, 58, has long studied cellular and molecular mechanisms that regulate airway smooth muscle cell growth and is involved in clinical investigations focused on the management of asthma and COPD, a group of diseases that cause airflow blockage and breathing-related problems, including emphysema, chronic bronchitis, and in some cases asthma.
 
According to the Centers for Disease Control and Prevention, more than 15 million Americans say that they have COPD.
 
Most recently, he has served as director of both the comprehensive asthma program for the University of Pennsylvania Health System and Penn’s Center of Excellence in Environmental Toxicology.
 
Currently, he and Vera Krymskaya are seeking FDA approval for a dual drug approach they’ve developed — rapamycin/simvastatin — to help fight a rare lung disease called lymphangioleiomyomatosis, known as LAM, which kills young women exclusively.
 
As institute director, Dr. Panettieri will seek to engage researchers throughout Rutgers’ undergraduate and graduate divisions in collaborative, interdisciplinary efforts to achieve common goals.  A major focus, Dr. Panettieri said, will be understanding the molecular makeup of disease and illnesses.
 
“We need to recognize that what we define as an illness very often is a result of many illnesses,” Dr. Panettieri said.  “We’ve got to become more precise so that physicians can prescribe medications and therapies that treat the right diseases.  Patients are our No. 1 priority. If they aren’t benefitting from the medications we prescribe, they won’t and shouldn’t take them.”
 
Dr. Panettieri’s overall goal is to speed up clinical and translational research and implementation, he said, enabling the institute to demonstrate it can support applications for National Institutes of Health clinical and translational science awards that significantly advance such research.
 
Though he has not yet created a priority plan, Dr. Panettieri says he will explore opportunities to enhance efforts surrounding COPD and asthma as he establishes the institute’s initial wave of research projects.
 
Setting the institute in motion and launching the training of clinical and translational researchers will achieve another goal for Strom and Panettieri — attracting and developing new researchers.
 
“Our legacy will not be what we publish,” Panettieri says, “but who we train as researchers. We’re striving to make this a premier program.”
0 Comments



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Healthcare
    Health Care
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Home   Coalition   News   Resources   Events   Join Us
Picture
Innovation New Jersey Coalition
10 West Lafayette Street
Trenton, NJ 08608-2002
609-858-9507